Buy SignalsTime the Stock, Not the Market

When you buy a stock is everything, but what's the right moment? These signals could indicate a buying opporunity.

*Not advice. Do your own research. Signal = investigate urgently, not buy blindly

Universe
Just a sec, loading data...Screen for Buy Signals →
Recent open-market buys by CEO/CFOs
Gross & net margins up 5%+ YoY
Trailing PE negative, forward PE positive
PEG ratio under 0.80
D/E dropped 25%+ in last 3 months
Rev growth +20pts YoY, P/S < 5
Dividend cuts or eliminations in the last 12 months
3 or more buy signals

Philosophy: Time the Business, Not the Technicals

These signals are built for long-term investors. None of them are technical indicators that try to predict the next few weeks of price action. The signals on this site are trying to identify businesses where something fundamental has changed — where the insiders are putting their own money to work, where the balance sheet is healing, where margins are widening, where growth is re-accelerating, or where a dividend has been cut to clean up its balance sheet. Those changes play out over quarters and years, not days.

Treat every signal here as "investigate now," not "buy." The same data point can mean two very different things. Insider buying could mean the CEO sees a turnaround beginning to work, or it could mean the CEO is trying to head-fake the market into following them. A dividend cut could mean management is freeing up cash to fund a real strategic pivot, or it could mean the business is going bankrupt. A growth re-acceleration could mean the company has cracked a new market, or it could be an accounting blip. The signals will produce false positives. That is fine. The point is to make you look at companies you would not otherwise consider.

I love feedback! Tell me what you think of these signals. Could they be improved? Which ones would you add? If you have a good idea, I'll add it. Contact me.

How I Beat the Market & What I'm Buying Now

I've beaten the market using these signals. I trippled my money on SoFi because I bought when the business was inflecting and the CEO was buying. He's buying again now...worth investigating. I bought Citi years ago when the balance sheet was improving and revenue re-accelerating; it's up 196% since.

My 3 Current Buys

I've been focused on finding health care stocks, given that the macro is murky and the sector is out of favor (read: undervalued). The three I like have new CEOs that are cleaning up the balance sheet and shedding unprofitable business lines. For Baxter and Dentsply Sirona, the signals that pushed me over the top recently were dividend cuts that "call the bottom" in my view. For Sanara MedTech, the signal was inflection, moving from negative to positive cash flow. I also spoke with the new management team and they are determined to refinance under better terms, the exact right move.

Inside Each Signal

A short summary of each signal, why it works, and when it doesn't. Tap any header for the full essay.

Insider Buying

Insider Buying: Why Open-Market Purchases by CEOs and CFOs Still Beat the Tape

When a CEO or CFO writes a personal check to buy more of their own stock on the open market, they are doing something they almost never do: voluntarily concentrating their wealth in the company they already work at. Decades of academic research, going back to H. Nejat Seyhun's 1986 paper and reinforced by more recent SEC and Jefferies studies, show insiders consistently beat the market by 6-10% annualized when buying. The signal works because executives have far better information about pipeline, customer demand, and earnings cadence than any analyst model. Cluster buys (multiple insiders buying inside a short window) and purchases at fresh 52-week lows are the highest-signal sub-patterns. Sells, by contrast, are noisy and mostly meaningless.

Read the full essay →
Bottomers

Bottomers: Why a Dividend Cut Can Mark the Bottom Instead of the Beginning of the End

Most investors treat a dividend cut as an unambiguous sell signal. The academic evidence and the historical record suggest the opposite is often true: by the time management is forced to cut, the stock has already absorbed most of the bad news, and the cut itself is what unlocks the capital flexibility needed for a turnaround. Studies by Healy & Palepu (1988) and subsequent work in the Journal of Financial Economics show that dividend cuts are typically followed by 1-2 quarters of further weakness and then a sharp recovery as the company redirects cash to debt paydown, buybacks at distressed prices, or productive reinvestment. The signal works best when the cut is large (50%+), the balance sheet is not catastrophic, and the underlying business has at least one credible path to stabilization.

Read the full essay →
Cheap Growers

Cheap Growers: The PEG Ratio Is Out of Fashion, Which Is Exactly Why It Still Works

Peter Lynch popularized the PEG ratio (price-to-earnings divided by earnings growth) in One Up On Wall Street and it remains one of the most reliable systematic ways to find businesses where growth is being underpriced. Lynch's rule of thumb — PEG below 1 is interesting, below 0.5 is potentially extraordinary — has been validated by multiple academic studies including Easton (2004) and Chan, Karceski & Lakonishok. The signal works because the market consistently underestimates the durability of growth in mid-cap businesses that lack analyst coverage and overpays for the apparent safety of mature large caps. A PEG under 0.80, paired with a credible growth path and a clean balance sheet, has historically delivered above-market returns with below-market drawdowns.

Read the full essay →
Inflecting Businesses

Inflecting Businesses: Why the Best Returns Come From the Crossover From Losing Money to Making It

The single most important re-rating event in a public company's life is the transition from negative to positive GAAP earnings. The market goes from valuing the business on revenue multiples or narrative to valuing it on earnings multiples, and the discontinuity in how the stock is screened, owned, and indexed produces some of the largest documented multi-year returns in equity markets. Academic work on the post-earnings inflection drift, including studies by Bernard & Thomas (1989) and later by McKinsey on margin transition events, shows that the market consistently underestimates the duration and magnitude of the operating leverage that kicks in once a business crosses into profitability. Trailing P/E negative, forward P/E positive is the cleanest mechanical screen for this transition.

Read the full essay →
Balance Sheet Clean Ups

Balance Sheet Cleanups: Deleveraging Is the Most Underrated Source of Equity Returns

When a company materially reduces its debt-to-equity ratio in a short window — typically through a combination of asset sales, equity issuance at a strategic moment, or aggressive free-cash-flow paydown — the equity is often dramatically rerated even though no operational improvement has occurred. Modigliani-Miller in its full form acknowledges that capital structure choices matter under real-world frictions like taxes, financial distress costs, and agency problems. The empirical record, including work by Korajczyk & Levy (2003) and a long line of corporate finance studies, shows that the equity re-rating following a clean deleveraging event averages 20-40% over the following 18 months. A 25%+ drop in debt-to-equity in one quarter is the strongest mechanical signal that this re-rating is in progress.

Read the full essay →
Reaccelerators

Reaccelerators: When Growth Re-Accelerates, the Multiple Expands Faster Than You Expect

The most powerful single moment in a growth stock's life cycle is the quarter where revenue growth visibly re-accelerates after a period of deceleration. Wall Street's relationship between revenue growth and revenue multiple is non-linear: a business going from 15% growth to 30% growth often sees its multiple double, producing a 4x stock return on a 2x revenue change. Research by Bessembinder (2018) on the long-tail distribution of equity returns shows that a handful of reaccelerating businesses drive the majority of index returns over multi-decade periods. The screen targets businesses whose latest quarter delivered at least 20 percentage points of growth re-acceleration versus the year-ago quarter while still trading at a price-to-sales multiple below 5x.

Read the full essay →
Moat Wideners

Moat Wideners: When Margins Expand Together, the Competitive Position Is Genuinely Strengthening

Warren Buffett popularized the concept of an economic moat — the durable structural advantage that protects a business from competition — and the academic literature on competitive advantage has since formalized the conditions under which a moat is observably widening rather than narrowing. The single most reliable mechanical signal of a strengthening moat is the simultaneous expansion of gross margin (pricing power) and net margin (operating leverage) over a 12-month horizon. Research by Porter, by HBR's work on sustained competitive advantage, and by Morningstar's moat-rating methodology all converge on the same conclusion: when gross and net margins both expand together, the business is gaining market share, gaining pricing power, or both. The screen requires at least 5 percentage points of expansion in each line over the trailing year.

Read the full essay →
Lollapalooza

Lollapalooza: When Multiple Buy Signals Stack, the Outcome Can Be Non-Linear

Charlie Munger borrowed the word 'lollapalooza' to describe situations where multiple powerful forces all push in the same direction at once — producing an outcome far larger than any single force could explain on its own. In equity investing, the equivalent is a stock that simultaneously triggers several independent buy signals: insider buying, a balance sheet in repair, an inflecting business, and a dividend cut that calls the bottom. Each signal on its own is a reason to look harder. Three or more signals firing together on the same stock is an invitation to look very hard. The research on factor combination consistently shows that signal stacking produces returns that are super-additive rather than merely additive — the whole is genuinely larger than the sum of its parts.

Read the full essay →
Inflecting

Sanara MedTech: Why This Small-Cap Wound Care Company Could Be a Big Winner

Sanara MedTech is a small-cap wound care and surgical products company quietly moving from negative to positive cash flow — the classic inflection signal. The new management team is on a determined path to refinance expensive debt, shed the underperforming dermatology business, and scale OsStic, a proprietary bone BioAdhesive that is barely reflected in the current stock price. If OsStic reaches even a fraction of its addressable market, the upside from here is not incremental — it is transformational. The risks are real: debt is still elevated, and the commission-heavy sales structure limits near-term operating leverage. But at today's price, you are paying almost nothing for the options that matter most.

Read the full essay →
Stock Analysis

SoFi Technologies: Why This Is One of the Most Compelling Stocks in the Market Right Now

SoFi Technologies started as a student loan refinancer and has quietly become a full-service digital bank with a technology platform that serves hundreds of other financial institutions. Getting its bank charter in 2022 was the turning point most investors missed. Anthony Noto has been buying the stock on the open market repeatedly — putting his own money behind a business he runs every day. Revenue is accelerating, the first profitable year is in the books, and the stock is still priced as if the transformation never happened. This is a rare case where the CEO's conviction, the business fundamentals, and the valuation all line up at once.

Read the full essay →
About this site & what I'm buying →